|
Volumn 97, Issue 3, 2002, Pages 649-653
|
Budesonide and mesalazine in active Crohn's disease: A comparison of the effects on quality of life
a b c d e f g h h |
Author keywords
[No Author keywords available]
|
Indexed keywords
BUDESONIDE;
MESALAZINE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROHN DISEASE;
DISEASE ACTIVITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PRIORITY JOURNAL;
PSYCHOLOGIC ASSESSMENT;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SCORING SYSTEM;
SYMPTOMATOLOGY;
WELLBEING;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-INFLAMMATORY AGENTS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BUDESONIDE;
CROHN DISEASE;
DOUBLE-BLIND METHOD;
FEMALE;
HEALTH STATUS;
HUMANS;
MALE;
MESALAMINE;
MIDDLE AGED;
QUALITY OF LIFE;
SEVERITY OF ILLNESS INDEX;
|
EID: 0036131469
PISSN: 00029270
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1572-0241.2002.05544.x Document Type: Article |
Times cited : (29)
|
References (17)
|